Vor Biopharma (VOR) Interest & Investment Income (2020 - 2026)
Vor Biopharma (VOR) reported Interest & Investment Income of $3.9 million for Q1 2026, up 388.82% year-over-year from $805000.0 in Q1 2025, and up 40.79% quarter-over-quarter from $2.8 million in Q4 2025.
Vor Biopharma (VOR) Interest & Investment Income (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Interest & Investment Income data on file, last reported at $3.9 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $3.9 million, up 388.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (up 153.18% YoY), and the FY2025 annual result was $5.9 million, up 37.39% from the prior year.
- Interest & Investment Income grew to $3.9 million in Q1 2026 per VOR's latest filing, from $2.8 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.9 million in Q1 2026 and troughed at $63000.0 in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.2 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 3057.14% in 2023, then plunged 67.85% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $815000.0 in 2022, then soared by 128.59% to $1.9 million in 2023, then sank by 67.85% to $599000.0 in 2024, then soared by 366.61% to $2.8 million in 2025, then surged by 40.79% to $3.9 million in 2026.
- Business Quant data shows VOR's Interest & Investment Income at $3.9 million in Q1 2026, $2.8 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Vor Biopharma | 621.09 Mn | 621.09 Mn | - | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 537,000.00 |
| Mar 31, 2025 | 805,000.00 |
| Dec 31, 2024 | 599,000.00 |
| Sep 30, 2024 | 954,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 815,000.00 |
| Sep 30, 2022 | 313,000.00 |
| Jun 30, 2022 | 133,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 10,000.00 |